Guilin Sanjin Pharmaceutical Co Ltd (002275) — Financial Flexibility Index
Guilin Sanjin Pharmaceutical Co Ltd (002275) has a Financial Flexibility Index of 0.23x as of September 2025. Free cash flow of CN¥241.88 Million (operating CF CN¥117.62 Million minus capex CN¥124.26 Million) represents 0% of total liabilities (CN¥1.05 Billion). Check cash flow reinvestment rate of Guilin Sanjin Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guilin Sanjin Pharmaceutical Co Ltd Financial Flexibility Index (2006–2024)
Historical Financial Flexibility Index trend for Guilin Sanjin Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Guilin Sanjin Pharmaceutical Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Guilin Sanjin Pharmaceutical Co Ltd (2006–2024)
Year-by-year free cash flow to debt coverage for Guilin Sanjin Pharmaceutical Co Ltd. Explore 002275 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.55x | CN¥670.51 Million | CN¥588.33 Million | CN¥1.22 Billion | ▼ -1.9% |
| 2023 | 0.56x | CN¥625.64 Million | CN¥549.25 Million | CN¥1.12 Billion | ▲ +8.9% |
| 2022 | 0.51x | CN¥590.93 Million | CN¥528.67 Million | CN¥1.15 Billion | ▲ +16.3% |
| 2021 | 0.44x | CN¥554.33 Million | CN¥410.24 Million | CN¥1.26 Billion | ▼ -49.3% |
| 2020 | 0.87x | CN¥803.46 Million | CN¥597.99 Million | CN¥923.27 Million | ▼ -24.8% |
| 2019 | 1.16x | CN¥694.43 Million | CN¥468.29 Million | CN¥600.18 Million | ▲ +8.1% |
| 2018 | 1.07x | CN¥641.69 Million | CN¥551.73 Million | CN¥599.47 Million | ▲ +37.1% |
| 2017 | 0.78x | CN¥449.35 Million | CN¥387.82 Million | CN¥575.65 Million | ▼ -42.4% |
| 2016 | 1.36x | CN¥602.21 Million | CN¥536.85 Million | CN¥444.26 Million | ▲ +7.9% |
| 2015 | 1.26x | CN¥523.51 Million | CN¥398.50 Million | CN¥416.59 Million | ▼ -4.3% |
| 2014 | 1.31x | CN¥607.81 Million | CN¥396.53 Million | CN¥463.07 Million | ▲ +1.8% |
| 2013 | 1.29x | CN¥627.00 Million | CN¥314.16 Million | CN¥486.11 Million | ▲ +3.4% |
| 2012 | 1.25x | CN¥508.22 Million | CN¥302.59 Million | CN¥407.26 Million | ▼ -41.8% |
| 2011 | 2.14x | CN¥467.80 Million | CN¥341.05 Million | CN¥218.18 Million | ▲ +1.3% |
| 2010 | 2.12x | CN¥383.93 Million | CN¥285.49 Million | CN¥181.47 Million | ▲ +41.2% |
| 2009 | 1.50x | CN¥417.97 Million | CN¥363.29 Million | CN¥279.00 Million | ▲ +147.1% |
| 2008 | 0.61x | CN¥229.61 Million | CN¥190.97 Million | CN¥378.65 Million | ▲ +16.5% |
| 2007 | 0.52x | CN¥181.98 Million | CN¥164.39 Million | CN¥349.58 Million | ▼ -56.9% |
| 2006 | 1.21x | CN¥246.82 Million | CN¥217.67 Million | CN¥204.48 Million | — |